Delcath Systems Inc (DCTH) - Gunggung Aset Perusahaan

Lambang korporat lan logo Delcath Systems Inc (DCTH)

This chart of Delcath Systems, Inc. (DCTH) total asset value on the GURU.Markets platform, which stands at 126.19, illustrates the business development of filters for local drug delivery to the liver. High barriers to entry are ensured by exclusive patents and stringent FDA oversight. Furthermore, the issuer's financial success does not depend on macroeconomics but relies exclusively on the implementation of innovative perfusion systems.

DCTH: Aset Agregat Perusahaan Delcath Systems Inc 04.07.2022 - 28.10.2026
Produk asil prodhuksi Delcath Systems

Investors utilize this metric as an indicator of the issuer's overall resource base and financial stability, specifically for Delcath Systems, Inc. (DCTH). The metric is calculated inversely via return on assets (ROA), determining the aggregate of controlled assets and liabilities. The price action in the valuation of the company's financial assets signals the pace of capital expansion or contraction. The stability of this value is supported by the flawless technical condition and planned capacity utilization of the perfusion system assembly plants.

Pesaing Delcath Systems, Inc. (DCTH)

beigene.com (ONC) - Nilai Agregat Aset|Total Aset Perusahaan HALO|Gunggung Aset Perusahaan Revolution Medicines Inc|Total Aset Perusahaan AAPG|Total Aset Perusahaan CGON (CG Oncology Therapeutics)|URGN - Aset Agregat Perusahaan|Total Aset Bisnis bicara.com BCAX|PSNL: Total Aset Perusahaan|ERAS - Gunggung Aset Perusahaan|Total Aset Perusahaan YMAB|AURA (Aura Corp) - Aset Perusahaan|CADL - Aset Agregat Perusahaan|Nilai Agregat Aset accuray.com (ARAY)|SELLAS Life Sciences (SLS) - Gunggung Aset Perusahaan|Nilai Agregat Aset Actuate Therapeutics Inc. (ACTU)|Citius Oncology, Inc - Total Aset Perusahaan|HURA - Gunggung Aset Perusahaan|Protara Therapeutics - Gunggung Aset Perusahaan|FATE: Total Aset Perusahaan|Aset Agregat Perusahaan aadibio.com WHWK|TScan Therapeutics, Inc. (TCRX) - Nilai Agregat Aset|Total Aset Perusahaan CSBR (Champions Oncology Inc)|Aset Perusahaan XBiotech USA|Total Aset Perusahaan CEL-SCI Corporation CVM|Total Aset Bisnis ostherapies.com (OSTX)|RADX: Total Aset Perusahaan|Artiva Biotherapeutics Inc. - Aset Perusahaan|ANL - Aset Agregat Perusahaan|VERU - Aset Agregat Perusahaan|TPST (Tempest Therapeutics) - Total Aset Perusahaan|Xilio Therapeutics (XLO) - Gunggung Aset Perusahaan|RENB (Renovaro Biosciences) - Total Aset Perusahaan|Total Aset Perusahaan Mural Bio (MURA)|Gunggung Aset Perusahaan Kairos Pharma Ltd|Aset Agregat Bisnis onkuretherapeutics.com (OKUR)|Total Aset Perusahaan CytoMed Therapeutics Limited|CRIS - Nilai Agregat Aset|Gunggung Aset Perusahaan Apollomics Corp (APLM)|THAR: Nilai Agregat Aset|advanbiomed.com - Aset Agregat Perusahaan|Gunggung Aset Perusahaan Genprex Inc|Gunggung Aset Perusahaan CLDI (Calidi Biotherapeutics Inc.)|Aset Perusahaan SBFM|XBIO (Xenetic Biosciences) - Aset Agregat Perusahaan|Gunggung Aset Perusahaan Salarius Pharmaceuticals Inc SLRX|Gunggung Aset Perusahaan Purple Biotech Corp (PPBT)|Aset Agregat Bisnis American Oncology Network Inc AONC|BGNE (BeiGene, Ltd.) - Total Aset Perusahaan|CKPT: Aset Perusahaan|ELEV (Elevation Oncology) - Aset Agregat Perusahaan|ICAD (iCAD) - Gunggung Aset Perusahaan|IKNA: Aset Agregat Perusahaan|Gunggung Aset Perusahaan Notable Labs Corp (NTBL)|Viracta Therapeutics (VIRX) - Gunggung Aset Perusahaan|Nilai Agregat Aset morphosys.com (MOR)|Total Aset Perusahaan NAYA|Ascentage Pharma Group International - Gunggung Aset Perusahaan